vs
agilon health, inc.（AGL）与Sunrun Inc.（RUN）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是Sunrun Inc.的1.4倍（$1.6B vs $1.2B），Sunrun Inc.净利率更高（8.9% vs -12.0%，领先21.0%），Sunrun Inc.同比增速更快（123.5% vs 3.1%），过去两年Sunrun Inc.的营收复合增速更高（59.0% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Sunrun Inc.是美国知名的光伏系统及电池储能产品供应商，业务以服务住宅客户为主，2007年成立，总部位于加利福尼亚州旧金山，致力于为家庭用户提供高效的清洁能源解决方案。
AGL vs RUN — 直观对比
营收规模更大
AGL
是对方的1.4倍
$1.2B
营收增速更快
RUN
高出120.4%
3.1%
净利率更高
RUN
高出21.0%
-12.0%
两年增速更快
RUN
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.2B |
| 净利润 | $-188.9M | $103.6M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | 8.4% |
| 净利率 | -12.0% | 8.9% |
| 营收同比 | 3.1% | 123.5% |
| 净利润同比 | -78.5% | 103.7% |
| 每股收益（稀释后） | — | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLRUN
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.4B | $724.6M | ||
| Q2 25 | $1.4B | $569.3M | ||
| Q1 25 | $1.5B | $504.3M | ||
| Q4 24 | $1.5B | $518.5M | ||
| Q3 24 | $1.5B | $537.2M | ||
| Q2 24 | $1.5B | $523.9M | ||
| Q1 24 | $1.6B | $458.2M |
净利润AGLRUN
| Q4 25 | $-188.9M | $103.6M | ||
| Q3 25 | $-110.2M | $16.6M | ||
| Q2 25 | $-104.4M | $279.8M | ||
| Q1 25 | $12.1M | $50.0M | ||
| Q4 24 | $-105.8M | $-2.8B | ||
| Q3 24 | $-117.6M | $-83.8M | ||
| Q2 24 | $-30.7M | $139.1M | ||
| Q1 24 | $-6.1M | $-87.8M |
营业利润率AGLRUN
| Q4 25 | -12.3% | 8.4% | ||
| Q3 25 | -9.1% | 0.5% | ||
| Q2 25 | -8.3% | -19.7% | ||
| Q1 25 | -1.4% | -22.8% | ||
| Q4 24 | -7.1% | -628.0% | ||
| Q3 24 | -9.2% | -23.8% | ||
| Q2 24 | -2.9% | -24.4% | ||
| Q1 24 | -0.4% | -40.0% |
净利率AGLRUN
| Q4 25 | -12.0% | 8.9% | ||
| Q3 25 | -7.7% | 2.3% | ||
| Q2 25 | -7.5% | 49.1% | ||
| Q1 25 | 0.8% | 9.9% | ||
| Q4 24 | -6.9% | -542.7% | ||
| Q3 24 | -8.1% | -15.6% | ||
| Q2 24 | -2.1% | 26.5% | ||
| Q1 24 | -0.4% | -19.2% |
每股收益（稀释后）AGLRUN
| Q4 25 | — | $0.38 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $1.07 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | $-12.59 | ||
| Q3 24 | — | $-0.37 | ||
| Q2 24 | — | $0.55 | ||
| Q1 24 | — | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | — |
| 总债务越低越好 | $35.0M | $14.7B |
| 股东权益账面价值 | $126.7M | $3.1B |
| 总资产 | $1.3B | $22.6B |
| 负债/权益比越低杠杆越低 | 0.28× | 4.69× |
8季度趋势，按日历期对齐
现金及短期投资AGLRUN
| Q4 25 | $173.7M | — | ||
| Q3 25 | $171.7M | — | ||
| Q2 25 | $171.4M | — | ||
| Q1 25 | $136.9M | — | ||
| Q4 24 | $188.2M | — | ||
| Q3 24 | $148.2M | — | ||
| Q2 24 | $109.5M | — | ||
| Q1 24 | $111.7M | — |
总债务AGLRUN
| Q4 25 | $35.0M | $14.7B | ||
| Q3 25 | — | $14.6B | ||
| Q2 25 | — | $14.0B | ||
| Q1 25 | — | $13.6B | ||
| Q4 24 | — | $12.9B | ||
| Q3 24 | — | $12.5B | ||
| Q2 24 | — | $12.0B | ||
| Q1 24 | — | $11.1B |
股东权益AGLRUN
| Q4 25 | $126.7M | $3.1B | ||
| Q3 25 | $306.1M | $3.0B | ||
| Q2 25 | $408.9M | $2.9B | ||
| Q1 25 | $500.3M | $2.6B | ||
| Q4 24 | $471.0M | $2.6B | ||
| Q3 24 | $574.9M | $5.3B | ||
| Q2 24 | $676.6M | $5.4B | ||
| Q1 24 | $689.3M | $5.2B |
总资产AGLRUN
| Q4 25 | $1.3B | $22.6B | ||
| Q3 25 | $1.6B | $22.2B | ||
| Q2 25 | $1.7B | $21.2B | ||
| Q1 25 | $1.9B | $20.4B | ||
| Q4 24 | $1.7B | $19.9B | ||
| Q3 24 | $2.1B | $22.1B | ||
| Q2 24 | $2.2B | $21.4B | ||
| Q1 24 | $2.3B | $20.8B |
负债/权益比AGLRUN
| Q4 25 | 0.28× | 4.69× | ||
| Q3 25 | — | 4.90× | ||
| Q2 25 | — | 4.80× | ||
| Q1 25 | — | 5.19× | ||
| Q4 24 | — | 5.05× | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 2.23× | ||
| Q1 24 | — | 2.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $96.9M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | — |
| 自由现金流率自由现金流/营收 | -1.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.94× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | — |
8季度趋势，按日历期对齐
经营现金流AGLRUN
| Q4 25 | $-20.5M | $96.9M | ||
| Q3 25 | $-18.2M | $-121.5M | ||
| Q2 25 | $-35.1M | $-292.7M | ||
| Q1 25 | $-32.0M | $-104.2M | ||
| Q4 24 | $16.4M | $-258.4M | ||
| Q3 24 | $-7.7M | $-156.2M | ||
| Q2 24 | $-18.7M | $-208.5M | ||
| Q1 24 | $-47.8M | $-143.1M |
自由现金流AGLRUN
| Q4 25 | $-23.5M | — | ||
| Q3 25 | $-21.3M | — | ||
| Q2 25 | $-38.3M | — | ||
| Q1 25 | $-35.8M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $-11.2M | $-156.4M | ||
| Q2 24 | $-22.0M | — | ||
| Q1 24 | $-50.9M | — |
自由现金流率AGLRUN
| Q4 25 | -1.5% | — | ||
| Q3 25 | -1.5% | — | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | -0.8% | -29.1% | ||
| Q2 24 | -1.5% | — | ||
| Q1 24 | -3.2% | — |
资本支出强度AGLRUN
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率AGLRUN
| Q4 25 | — | 0.94× | ||
| Q3 25 | — | -7.33× | ||
| Q2 25 | — | -1.05× | ||
| Q1 25 | -2.64× | -2.08× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.50× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RUN
| Products | $692.3M | 60% |
| Customer Agreements | $435.2M | 38% |
| Manufactured Product Other | $56.7M | 5% |
| Incentives | $31.3M | 3% |
